Details of the Drug Formulaction

General Information of Drug Formulation (ID: F14853)

• Formulation Name: Naloxegol 25 mg tablet
• Company: AstraZeneca; Avera McKennan Hospital; Lake Eire Medical & Surgical Supply DBA Quality Care Products

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Naloxegol	(DML0B41)	Opioid-induced constipation	DB32.1	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Eisenoxyd	(E00585)	56841934	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Propyl gallate	(E00075)	4947	Antimicrobial preservative; Antioxidant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Water	(E00035)	962	Solvent